LEPR and cardiomyopathy: Finally, we examined the impact of CM-specific LIPTER transgene on cardiomyopathy of leptin-receptor-deficient Leprdb/db mouse (Fig. 7o), a model of T2DM and obesity that develops cardiac hypertrophy and dysfunction from 10 weeks of age42,43.